These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10738843)

  • 61. Meropenem, a new carbapenem antibiotic.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(4):644-69. PubMed ID: 9250544
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neurological complication during imipenem/cilastatin therapy in uraemic patients.
    Campise M
    Nephrol Dial Transplant; 1998 Jul; 13(7):1895-6. PubMed ID: 9681765
    [No Abstract]   [Full Text] [Related]  

  • 63. Selecting therapy for serious infections in children: maximizing safety and efficacy.
    Bradley JS
    Diagn Microbiol Infect Dis; 1998 Jun; 31(2):405-10. PubMed ID: 9635916
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.
    Ong CT; Kuti JL; Nicolau DP;
    Surg Infect (Larchmt); 2005; 6(4):419-26. PubMed ID: 16433606
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Formulary review of the carbapenems: comparison of imipenem/cilastatin and meropenem.
    Richerson MA; Ambrose PG; Quintiliani R; Nightingale CH
    Conn Med; 1998 Mar; 62(3):165-9. PubMed ID: 9573653
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem.
    Norrby SR; Newell PA; Faulkner KL; Lesky W
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():207-23. PubMed ID: 8543496
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Seizure activity associated with imipenem use: clinical case reports and review of the literature.
    Leo RJ; Ballow CH
    DICP; 1991 Apr; 25(4):351-4. PubMed ID: 1926901
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.
    Romanelli G; Cravarezza P; Pozzi A; Franchino L; Ravizzola G; Zulli R; Donati P; Prometti P; Grassi V
    J Chemother; 2002 Dec; 14(6):609-17. PubMed ID: 12583553
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Meropenem: a review of its use in the treatment of serious bacterial infections.
    Baldwin CM; Lyseng-Williamson KA; Keam SJ
    Drugs; 2008; 68(6):803-38. PubMed ID: 18416587
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Study of the efficacy and tolerance of imipenem-cilastatin used as monotherapy for the adjuvant treatment to surgery of peritonitis. Results of a French multicenter study including 257 patients].
    Midy D; Pometan JP; Baste JC; Pajadon V
    J Chir (Paris); 1992; 129(6-7):303-8. PubMed ID: 1474112
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
    Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
    Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost-effectiveness study of imipenem/cilastatin versus meropenem in intra-abdominal infections.
    Attanasio E; Russo P; Carunchio G; Basoli A; Caprino L
    Dig Surg; 2000; 17(2):164-72. PubMed ID: 10781982
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The role of meropenem in bacterial meningitis].
    Fernández Viladrich P
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():57-61. PubMed ID: 9410071
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cross-reactivity and tolerability of imipenem in patients with delayed-type, cell-mediated hypersensitivity to beta-lactams.
    Schiavino D; Nucera E; Lombardo C; Decinti M; Pascolini L; Altomonte G; Buonomo A; Patriarca G
    Allergy; 2009 Nov; 64(11):1644-8. PubMed ID: 19392998
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem.
    Linden P
    Drug Saf; 2007; 30(8):657-68. PubMed ID: 17696578
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group.
    Odio CM; Puig JR; Feris JM; Khan WN; Rodriguez WJ; McCracken GH; Bradley JS
    Pediatr Infect Dis J; 1999 Jul; 18(7):581-90. PubMed ID: 10440432
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections.
    Edwards SJ; Emmas CE; Campbell HE
    Curr Med Res Opin; 2005 May; 21(5):785-94. PubMed ID: 15969878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.